Protection against Leishmania donovani infection by DNA vaccination: Increased DNA vaccination efficiency through inhibiting the cellular p53 response

Vaccine

Volumn 19, Issue 23-24, 2001, Pages 3169-3178

  Ghosh, Anirban ^a   Labrecque, Sylvie ^a   Matlashewski, Greg ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

DNA vaccine; HPV E6; Leishmania; p53

Indexed keywords

DNA VACCINE; PROTEIN P53;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA TRANSFECTION; GENE EXPRESSION; GENOME; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; LEISHMANIA DONOVANI; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; WART VIRUS;

ANIMALS; ANTIBODIES, PROTOZOAN; BASE SEQUENCE; CELL LINE; DNA PRIMERS; FEMALE; GENE DELETION; GENES, P53; GENES, PROTOZOAN; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MICE; MICE, INBRED BALB C; PROTOZOAN VACCINES; T-LYMPHOCYTES, HELPER-INDUCER; TRANSFECTION; VACCINES, DNA; VIRULENCE;

EID: 0035972008     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00023-8     Document Type: Article

References (45)

1. Leishmaniasis
2. Visceral leishmaniasis: More prevalent and more problematic
3. Clinical spectrum of leishmaniasis
4. Developmental gene expression in Leishmania donovani: Differential cloning and analysis of an amastigote stage-specific gene
5. The developmental expression of Leishmania donovani A2 amastigote specific genes is post-transcriptionally mediated and involves elements located in the 3′ UTR
6. Identification and of the A2 amastigote specific protein in Leishmania donovani
7. Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2
8. Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis
9. Genetic immunization: A simple method for eliciting an immune response
10. Exposing the immunology of naked DNA
11. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations
12. The immunology of DNA vaccine
13. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen
14. Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12
15. Improvement of hepatitis B virus DNA vaccine by plasmids coexpressing hepatitis B surface antigen and interleukin-2
16. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines
17. CD28/B7 system of T cell costimulation
18. Co-stimulation of T cell response
19. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
20. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin-6, interleukin-12 and interferon-γ
21. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
22. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvant
23. p53: Guardian of the genome
24. p53, the cellular gatekeeper for growth and division
25. Signaling to p53: Breaking the MDM-p53 circuit
26. Regulation of p53 stability
27. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways
28. Sensitivity and selectivity of the DNA damage sensor responsible for activating p53 dependent G1 arrest
29. p53-dependent growth arrest following calcium phosphate-mediated transfection of murine fibroblasts
30. The role of the E6-p53 interactions in the molecular pathogenesis of HPV
31. Human papillomavirus-induced carcinogenesis with p53-deficiency in mouse: Novel lymphoma genesis in HPV 16 E6 transgenic mice mimicking p53 deficiency
32. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals
33. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis
34. Leishmaniasis in hamster
35. Serodiagnosis of Leishmaniasis with recombinant orf-F antigen
36. Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus iscoms
37. DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6
38. Biscistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein
39. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression
40. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice
41. Interferon-gamma and B-cell stimulatory factor-1 reciprocally regulate Ig isotype production
42. A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis
43. Inhibition of viral and cellular promoters by human wild-type p53